Business
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
SARASOTA, Fla., Sept. 28, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused
About this update from Invo Fertility, Inc.
[{"type":"text","content":"SARASOTA, Fla., Sept. 28, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) (\"INVO\" or the \"Company\"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture (\"IVC\") procedure it enables, reminds its shareholders to vote ahead of the upcoming special meeting of shareholders (the \"Special Meeting\") to be held on September 29, 2023 at 12:00 pm (Eastern time). The Board of Directors of INVO (the \"Board\") unanimously recommends that the Company's shareholders vote \"FOR\" all proposals. Only shareholders of record as of the close of business on August 21, 2023 will be entitled to notice of, and to vote at, the Special Meeting.\n\n \n \n \n \n \n \n\n \n\"We encourage our shareholders to vote for the proposals in order to provide the company the ability to capitalize on its recent progress and continue its growth objectives,\" commented Steve Shum, CEO of INVO.\nAll votes are important, regardless of the number of shares owned. Shareholders as of Special Meeting record date, August 21, 2023, will be entitled to vote at the Special Meeting. Shareholders are encouraged to read about the proposals in the Company's Definitive Proxy Statement on Schedule 14A that was filed with the Securities and Exchange Commission (\"SEC\") on September 1, 2023 (the \"Proxy Statement\")\nIn addition to voting by submitting your proxy prior to the Special Meeting, you also will be able to vote your shares electronically during the Special Meeting. Further details regarding the virtual meeting are included in the Proxy Statement sent to all shareholders. At the Special Meeting, the holders of our outstanding common stock will act on the following matters:\nTo approve an increase to the number of authorized shares of common stock of the Company from 6,250,000 shares to 50,000,000 shares (the \"Authorized Share Increase\");To approve, for the purposes of Nasdaq Marketplace Rule 5635(d), the reduction of the exercise price for the March 2023 private placement warrants from $12.60 per share to $2.85 per share (the \"Warrant Exercise Price Reduction\"); andTo transact such other business as may properly be brought before the Special Meeting or any adjournment or postponement thereof.If you are a shareholder of record, you may vote in on...